ISCA Meeting Abstract Submission

International Symposium on Chromosomal Aberrations

Abstract Submission Guidelines

Call for Abstracts is now closed!

 

Important Dates:

Call for Abstracts Opens:                               24 January 2018

Abstract Submission Deadline:                  31 March

Notification of Review Outcome:               End of April


Submission Process

  • The Presenting Author must submit the abstract and is required to be the corresponding author for that abstract
  • Abstracts must be submitted in English

You do not need to register for the Meeting prior to submitting an abstract however following acceptance into the programme.


Presentation Type

An abstract can be submitted for presentation at the ISCA Meeting as one of the following categories:

  • Oral or Poster Presentation
  • Poster Presentation

At the review stage, the Programme Committee may change the presentation type submitted by the author to ensure the continuity of the meeting programme i.e. oral presentation may be changed to poster presentation OR poster presentation to oral presentation. The presenting Author will be informed of any change to their submitted presentation type at the acceptance notification stage. The decision of the programme committee is final.

Oral Format:

Oral presentations will be either 20 minutes including questions and answers (or 10 minutes long for short, selected presentations).

Poster Format:

Accepted posters will be asked to produce a poster for display at the conference. Presenters are asked to take note of the following guidelines when producing their poster:

  • Maximum poster size is A0 (0.84 x 1.19m) (portrait orientation)
  • Keep text to a minimum
  • Ensure any text is in large font
  • Use graphs, charts, and/or tables
  • Ensure contents have a logical flow
  • Make it colourful
  • Removal and collection of posters at the end of the day remains the responsibility of the presenter.

Topics

State-of-the-art technologies for basic and applied aspects of chromosomal aberrations, the elucidation of the mechanisms underlying their formation and their impact on chromosome fragility, genomic instability and carcinogenesis. The Symposium will give the opportunity to the invited speakers and participating scientists to present their work and share their vision on the latest achievements which are NOT limited in the following research topics:

  1.    Mechanisms of formation of chromosome and chromatid aberrations
  2.    Mechanisms of formation of micronuclei
  3.    Premature Chromosome Condensation (PCC)
  4.    Chromosomal instability
  5.    Cytogenetic biomonitoring of human populations
  6.    Chromosome aberrations based biodosimetry for radiation risk assessment
  7.    Cancer cytogenetics / Chromosome fragility syndromes / Chromothripsis & cancer
  8.    Role of telomeres and centromeres in formation of chromosome aberration
  9.    Nuclear architecture, Chromosome exchanges, Modeling
  10.    New technologies for chromosome aberration detection / Automation
  11.    Whole genome sequencing, opportunities and limitations

What to include in your abstract?

  • Title of the abstract (word limit is 20)
  • Presentation type (Oral or Poster)
  • The name, affiliations and contact email must be included for the presenting author and co-author(s). The presenting author must be listed as the first author.
  • Name, affiliation, and email of co-author(s)
  • Abstract word limit is 250, excluding Title, Authors and Affiliations
  • The abstract should contain information concerning the background of the research, aims, methods used and any key results and conclusions.
  • Complete questions listed in Additional Information:
    • Please provide 3 Keywords:
    • Are you an early career scientist – up to 5 years? yes/no
    • Please indicate which society you are a member of:
    • Please indicate your professional status:

Where to submit your abstract?

Please email your abstract document to Christophe Badie Christophe.Badie@phe.gov.uk by Sunday 31 March.

IMPORTANT: DO NOT SUBMIT your abstract to the General ICRR abstract submission portal.

 


Questions?

Contact Christophe Badie Christophe.Badie@phe.gov.uk